Oppenheimer & Co’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-119,600
| Closed | -$853K | – | 1334 |
|
|
2020
Q1 | $853K | Buy |
119,600
+106,900
| +842% | +$762K | 0.03% | 577 |
|
|
2019
Q4 | $303K | Sell |
12,700
-10,216
| -45% | -$244K | 0.01% | 1019 |
|
|
2019
Q3 | $614K | Buy |
22,916
+393
| +2% | +$10.5K | 0.02% | 727 |
|
|
2019
Q2 | $611K | Buy |
22,523
+318
| +1% | +$8.63K | 0.02% | 740 |
|
|
2019
Q1 | $771K | Sell |
22,205
-2,551
| -10% | -$88.6K | 0.02% | 663 |
|
|
2018
Q4 | $483K | Sell |
24,756
-36,434
| -60% | -$711K | 0.02% | 742 |
|
|
2018
Q3 | $1.63M | Buy |
61,190
+47,594
| +350% | +$1.27M | 0.04% | 455 |
|
|
2018
Q2 | $514K | Sell |
13,596
-8,003
| -37% | -$303K | 0.01% | 850 |
|
|
2018
Q1 | $705K | Buy |
21,599
+16,354
| +312% | +$534K | 0.02% | 732 |
|
|
2017
Q4 | $256K | Buy |
+5,245
| New | +$256K | 0.01% | 1122 |
|